| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/12/2006 | CN1263442C Hair growth stimulant compositions with sustained action |
| 07/11/2006 | US7074907 Plant extracts; antioxidant ; stability; whitening agent ; foods, cosmetics |
| 07/11/2006 | US7074806 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
| 07/11/2006 | US7074802 analgesics; antipyretics; antiinflammatory agents; antiarthritic agents |
| 07/11/2006 | US7074801 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| 07/11/2006 | US7074800 Quinazoline derivatives as angiogenesis inhibitors |
| 07/11/2006 | US7074799 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 07/11/2006 | US7074794 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor |
| 07/11/2006 | US7074793 KInase inhibitor; Alzheimer's disease; central nervous system disorders; antiinflamamtory agents; skin disorders; osteoporosis; atherosclerosis; restenosis; thrombosis; antidiabetic agents; viricides; fungicides |
| 07/11/2006 | US7074778 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 07/11/2006 | US7074777 Vitamin D derivatives |
| 07/11/2006 | US7074766 antiinflammatory agents; autoimmune diseases; thrombosis; viricides; blood disorders; antitumor agents |
| 07/11/2006 | US7074420 Cosmetic treatment using a new retinoid |
| 07/11/2006 | US7074408 Use of integrin antagonists to inhibit angiogenesis |
| 07/11/2006 | US7074406 Treating allergic diseases with humanized anti-CD40L antibody |
| 07/11/2006 | US7074392 for high penetration into fingernails and toenails; contains humectant for trapping water and liquid nail lacquer containing film forming agent |
| 07/11/2006 | CA2395114C 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 07/11/2006 | CA2319201C Celecoxib compositions |
| 07/11/2006 | CA2285548C Nicotinamide derivatives |
| 07/11/2006 | CA2262566C Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect |
| 07/11/2006 | CA2244256C Antipruritic |
| 07/11/2006 | CA2158609C 5 .alpha.-reductase inhibitors |
| 07/06/2006 | WO2006071035A1 Novel ([1,3]thiazolo[5,4-b]pyridin-2-yl)-2-carboxamide derivatives |
| 07/06/2006 | WO2006070927A1 Pyrimidinylisoxazol derivative |
| 07/06/2006 | WO2006070921A1 Type iv/type vii collagen production accelerator |
| 07/06/2006 | WO2006070726A1 N-acetylglucosamine tablet disintegrating in oral cavity and process for producing the same |
| 07/06/2006 | WO2006070705A1 Intraoral disintegration type solid preparation containing povidone iodine |
| 07/06/2006 | WO2006070093A1 Composition comprising solubilized adapalene with cyclodextrins |
| 07/06/2006 | WO2006069540A1 Burn-treating drug delivery system containing trehalose and hyaluronic acid and its producing method |
| 07/06/2006 | WO2006069417A1 A method of treatment |
| 07/06/2006 | WO2006057900A3 17,20(z)-dehydro vitamin d analogs and their uses |
| 07/06/2006 | WO2006057899A3 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses |
| 07/06/2006 | WO2005077400A8 Cysteine rich peptides for improving thiol homeostasis |
| 07/06/2006 | US20060149039 Pseudo-native chemical ligation |
| 07/06/2006 | US20060149033 IGF antagonist peptides |
| 07/06/2006 | US20060148862 Novel compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 07/06/2006 | US20060148825 1-[Alkyl], 1-[(heteroaryl) alkyl] and 1-[(Aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1H)-one derivatives |
| 07/06/2006 | US20060148824 Administering compounds such as 6-Chloro-N-[(1R)-1-phenylethyl]pyrazin-2-amine for inhibiting a protein kinase |
| 07/06/2006 | US20060148819 Chemical compounds |
| 07/06/2006 | US20060148814 4-(2-Pyridyl)-1-amino(thio)carbonylpiperazine derivatives are antagonists of the mGluR5 receptor |
| 07/06/2006 | US20060148802 Use of compounds that stimulate cgmp |
| 07/06/2006 | US20060148798 Antiinflammatory agents; cardiovascular disorders; antidiabetic agents;central nervous system diosrders ; anticancer agents |
| 07/06/2006 | US20060148792 Substituted 1,4-benzodiazepines and uses thereof |
| 07/06/2006 | US20060148769 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 07/06/2006 | US20060148768 Vitamin d3 lactone derivatives |
| 07/06/2006 | US20060148751 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 07/06/2006 | US20060148732 Inhibition of NF-kappaB by triterpene compositions |
| 07/06/2006 | US20060148698 Storage-stable fibrinogen solutions |
| 07/06/2006 | US20060148018 Insulin-like growth factor binding protein-4 protease |
| 07/06/2006 | US20060147548 Therapeutic delivery of carbon monoxide |
| 07/06/2006 | US20060147488 increasing tear resistance of scar tissue during wound repair by applying to a wound a surgical mesh comprising an anabolic steroid and a corticosteroid disposed in or on a surgical mesh structure |
| 07/06/2006 | US20060147446 Humanized antibodies to human GP39, compositions, and therapeutic uses thereof |
| 07/06/2006 | US20060147401 Skin material for external use and antiprutiric agent for external use and wrinkle-instrument using the same |
| 07/06/2006 | US20060147397 Composition for preparation for external use on skin and method of using the same |
| 07/06/2006 | US20060147393 Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas |
| 07/06/2006 | US20060147383 Sprayable compositions comprising pharmaceutical active agents, volatile silicones and a non-volatile oily phase |
| 07/06/2006 | US20060146644 System for producing micro-cluster liquids |
| 07/06/2006 | CA2591912A1 Pyrimidinylisoxazole derivatives |
| 07/06/2006 | CA2591294A1 Composition comprising solubilized adapalene with cyclodextrins |
| 07/05/2006 | EP1676915A2 Ribozyme therapy for the treatment of proliferative skin diseases |
| 07/05/2006 | EP1676912A2 Medical equipment containing a polypeptide having heparanase activity |
| 07/05/2006 | EP1676846A2 Hydantoin derivatives as MMP inhibitors |
| 07/05/2006 | EP1676845A1 New quinazoline derivatives |
| 07/05/2006 | EP1675603A1 Use of probiotic bacteria in the treatment of infection |
| 07/05/2006 | EP1675586A1 Methods for treating non-microbial inflammatory skin conditions |
| 07/05/2006 | EP1675557A1 Composition comprising a sesquiterpene lactone |
| 07/05/2006 | EP1467744A4 Aqueous compositions containing metronidazole |
| 07/05/2006 | EP1418881A4 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide |
| 07/05/2006 | EP1390049B1 Compositions for treating animal diseases and syndromes comprising transfer factor |
| 07/05/2006 | EP1389044A4 Ppar-alpha-gamma ligands or agonists for the treatment of inflammation |
| 07/05/2006 | EP1385505B1 Acne treatment with lipooxigenase inhibitors |
| 07/05/2006 | EP1274473B1 Antimicrobial bioabsorbable materials |
| 07/05/2006 | EP1259241B1 The use of scopolamine salts |
| 07/05/2006 | EP1259240B1 Agents, such as nicotinamide or cadpr for the treatment of skin disorders |
| 07/05/2006 | EP1225894B1 Fab i inhibitors |
| 07/05/2006 | EP1028727B1 Skin penetration enhancing components |
| 07/05/2006 | CN1798742A Novel biaromatic compounds which activate ppar [upsilon] pharmaceutical compsns |
| 07/05/2006 | CN1798568A Formulation of dual cycloxygenase (cox) and lipoxygenase (lox) inhibitors for mammal skin care |
| 07/05/2006 | CN1798565A Material promoting wound healing |
| 07/05/2006 | CN1798550A Use of diphenylmethane derivatives as tyrosinase inhibitors |
| 07/05/2006 | CN1796394A Extractive form active ingredient of bitter bamboo, prepartion method and application |
| 07/05/2006 | CN1795926A Methods for treating skin conditions |
| 07/05/2006 | CN1795922A Agent promoting the formation of skin basement membrane, agents promoting the formation of artificial skin and process for producing artificial skin |
| 07/05/2006 | CN1795916A Medication of prolonging life for dispelling senile plaque, and preparation method |
| 07/05/2006 | CN1795911A Medicament for treating leucoderma and prepartion method |
| 07/05/2006 | CN1795904A Spray agent for burn and scald |
| 07/05/2006 | CN1795876A Towel of freshening and cooling skin |
| 07/05/2006 | CN1795872A Application of serum of umbilical cord blood in treating scar of wound |
| 07/05/2006 | CN1262560C 4-halogenated 17-methylene steroids, method for production thereof and pharmaceutical compositions contg. these compounds |
| 07/05/2006 | CN1262541C Tricyclic protein kinase inhibitors |
| 07/05/2006 | CN1262540C Bicycle androgen and progesterone receptor modulator compounds and methods |
| 07/05/2006 | CN1262304C Chinese medical preparation for treating dermatitis, eczema, herpes and herpes zoster |
| 07/05/2006 | CN1262302C Exterior-applied medicine for treating beriberi and tinea pedis and its preparing process |
| 07/05/2006 | CN1262300C Medicinal liquid for Hong Kong foot |
| 07/05/2006 | CN1262287C Externally applied medicine for treating skin cold injury, swelling and pain, fester and subdermal cyst and its preparation method |
| 07/05/2006 | CN1262285C Liniment for skin and its preparation |
| 07/05/2006 | CN1262281C Drugs, foods, drinks and feeds containing cocoa component |
| 07/05/2006 | CN1262279C Medicine for external application for treating psora |
| 07/05/2006 | CN1262274C Complexes of phosphate derivatives |
| 07/05/2006 | CN1262267C Speckle removing and whitening traditional medicinal healthy product and its preparation |